ClinicalTrials.gg
TerminatedNCT03284060RCKIDUpdated Jan 9, 2020

Social Cognition Training and Cognitive Remediation

An interventional study of Cognitive remediation program in 22q11.2 Deletion Syndrome, sponsored by Hôpital le Vinatier. Terminated at 1 site in France. Open to participants aged 5 Years to 13 Years. Per ClinicalTrials.gov, last updated 2020-01-09.

Sponsored by Hôpital le Vinatier · Not applicable, Interventional, and Treatment

Why this study was terminated
inclusion difficulties
Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Not applicable
Ages
5 Years to 13 Years
Sex
All
01

Study summary

Social cognition refers to mental operations that enable people to perceive, interpret constantly changing social informations. These processes allow people to rapidly, effortlessly and flexibly perceive and interpret rapidly-changing social information, and respond appropriately to social stimuli. Besides, this ability gives meaning to the actions of others. Impairments in this field may largely underlie social dysfunctions and reduce adaptive skills. Moreover, social cognitive disabilities contribute more or less directly to behavioral disturbances and psychiatric symptoms The "RC KID" program involves a variety of exercises in a paper and/or pencil or a computerized format or role playing and a strategy coaching approach. "RC KID" targets the emotion recognition and social interaction.

A little cartoon character (a pirate), is supposed to be very friendly and kind toward children. The pirate will accompany them throughout the program for an effective and positive reinforcement. The main goal of "RC KID" is to adjust to children's difficulties in daily life.

Moreover, since the cognitive remediation benefit is complex to apply in daily life, the program is based on a metacognitive strategy.

After a complete neuropsychological assessment and a psychoeducational session (with the child and the parents), 16 1-h-sessions of cognitive remediation with the therapist are proposed. Each session is composed of three parts: (1) computerized tasks focusing on specific emotion recognition components (20 min). RC KID is composed of 2 modules : Emotion recognition and social interaction. These tasks contain photo or video. (2) pen and paper or role playing tasks focusing on the same processes (20 min) (3) a proposal of a home-based task (during 20 min). Weekly, home tasks are proposed to the child and analyzed with the parents and the therapist. Indeed, home exercises are useful to promote the transfer of strategies to daily life and their subsequent automation. The heterogeneity of cognitive deficits in 22q11.2 deletion necessitates an individualized cognitive remediation therapy. In this regard, "RC KID" seems to be a promising tool.

Read the detailed description

The second objective is to evaluate the impact of RC KID on behavior disorders. Method : a validation study using multiple single-case experimental designs. A thorough assessment, including a complete evaluation of components of social cognition but also clinical and neuropsychological assessments is proposed for each patient enrolled in the study.

Investigators collect three kinds of baselines before the beginning of the cognitive remediation intervention: baselines specific of the targeted component (Emotion recognition and Theory of Mind), non-specific baselines (such as measures of neurocognition processes that should not be affected by the intervention), and intermediary baselines that is measures of social cognitive function linked with targeted processes but not directly concerned by the cognitive remediation program.

These measures and the complete assessment will be repeated at the end of the intervention to highlight impacts of RC KID on social cognitive impairments, and 6 months later to investigate the possible long-lasting effects of the benefits.

02

Conditions studied

  • 22q11.2 Deletion Syndrome

Browse trials for

Keywords

  • Cognitive remediation, 22q11.2 deletion syndrome
03

In context

DiGeorge Syndrome

47 studies on the registry are indexed under DiGeorge Syndrome; 11 are open to participants now.

This study's enrollment of 3 is below the median of 26 across 27 interventional studies indexed under DiGeorge Syndrome.

Browse DiGeorge Syndrome studies →

Lead sponsor

Hôpital le Vinatier is the lead sponsor of 106 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children with diagnosis of 22q11.2 deletion syndrome (CGH-Array and FISH)
  • Native French speaker
  • Clinically stable
  • Parental and children consent

Exclusion criteria

Exclusion Criteria:

  • history of neurological illness or trauma
  • Taking of medicine with somatic aim having a cerebral or psychic impact
  • Simultaneous participation on another program of cognitive remediation
  • child or parents unlikely to cooperate
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
3 participants (actual)

Study arms

  • Experimental
    Cognitive remediation program

    Behavioral: Cognitive remediation program

Interventions

  • BehavioralCognitive remediation program

    Cognitive remediation program is a set of reeducation techniques and aims at restoring or compensating altered cognitive functions such as memory, attentional or executive functions, and social cognition. Therapists help individuals develop new information processing strategies designed to meet their needs and wishes. Specific therapeutic sessions are designed to generalize such strategies to everyday situations to reduce the impact of cognitive deficits on daily life. Thus, social cognitive training therapy helps the development of personal strategies specifically adapted to preserve skills and reduce the difficulties. 16 sessions (45 min) of cognitive remediation with the therapist are proposed, each session is composed of three parts: 1. pen and paper tasks focusing on specific emotion recognition component (20 min), 2. computerized tasks focusing on the same process (20 min), 3. a proposal of a home-based task (during 20 min).

06

What researchers measure

Primary outcomes

  1. The primary endpoint is the variation in sub-scores of specific baselines, obtained before and after cognitive remediation intervention:

    baselines specific of the targeted component (Emotion recognition and Theory of Mind), non-specific baselines (such as measures of neurocognition processes that should not be affected by the intervention), intermediary baselines that is measures of social cognitive function linked with targeted processes but not directly concerned by the cognitive remediation program. These measure is repeated at the end of the intervention to highlight the impact of the " RCKID " program, and 6 months later to investigate the possible long-lasting effects of the benefits

    Time frame: 6 months

Secondary outcomes

  1. Aberrant Behavior Checklist scale

    Change in sub-score " hyperactivity / non compliance " (scale " Aberrant Behavior Checklist ") (completed by parents or the educational team). This measure is repeated at the end of the intervention to highlight the impact of the " RC KID " program, and 6 months later to investigate the possible long-lasting effects of the benefits.

    Time frame: 6 months

  2. MDI-C scale ( Multiscore Depression Inventory for Children scale)

    Time frame: 6 months

  3. KIDSCREEN-27 scale

    The KIDSCREEN-27 with five dimensions resulted. All five dimensions are Rasch scales: Physical Well-Being (5 items), Psychological Well-Being (7 items), Autonomy \& Parents (7 items), Peers \& Social Support (4 items), and School Environment (4 items).

    Time frame: 6 months

  4. Vineland 2 scale (Vineland Adaptive Behavior Scale)

    A measure of adaptive behavior from birth to adulthood

    Time frame: 6 months

07

Study locations

1 site
  • Hopital Vinatier
    Lyon, Rhone Alpes 69678, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2017 to primary completion in Mar 2018, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2017
First posted
Sep 15, 2017
StartActual
Oct 11, 2017
Primary completionActual
Mar 9, 2018
CompletionActual
May 21, 2019
Last update
Jan 9, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03284060
Responsible party
Sponsor
First posted
Sep 15, 2017
Start date
Oct 11, 2017
Primary completion
Mar 9, 2018
Completion
May 21, 2019
Last update
Jan 9, 2020

Study contacts

DEMILY CAROLINE, PH
principal investigator · Centre Hospitalier le Vinatier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion